| abstract |
CD33 ligands which are useful for the synthesis of CD33 ligand- bearing carriers, wherein said CD33 ligand-bearing carriers are directly or indirectly linked to or associated with at least one anti- cancer agent, are described herein. Uses of said CD33 ligand- bearing carriers for treating and/or preventing a disease, disorder, or condition such as acute myeloid leukemia (AML) are also described. The CD33 ligands have the structure of formula (I): |